1. Halstead SB. Dengue Fever and Dengue Hemorrhagic Fever, 2007.

In:
Nelson Textbook of Pediatrics 18th ed. Philadelphia: Saunders Elsevier, 1442-
1414.
2. World Health Organization. Classification of Dengue Hemorrhagic Fever;
2013 [cited 01 March 2020]. Available from : http://www.searo.who.int/EN/
3. Martina BEE, Koraka P, Osterhaus ADME. Dengue virus pathogenesis: an
integrated view. Clin Microbiol Rev. 2009; 22(4):564.
4. Limon-Flores AY, et al. Dengue virus inoculation to human skin explants:
an effective approach to assess in situ the early infection and the effects on
cutaneous dendritic cells. Int. J. Exp. Pathol. 2005; 86:323-334.
5. Wu SJ, et al. Human skin Langerhans cells are targets of dengue virus
infection. Nat. Med. 2000; 6:816-820.
6. Durbin AP, et al. Phenotyping of peripheral blood mononuclear cells during
acute dengue illness demonstrates infection and increased activation of
monocytes in severe cases compared to classic dengue fever. Virology. 2008;
376:429-435.
7. Kou ZM, et al. Monocytes, but not T or B cells, are the principal target cells
for dengue virus (DV) infection among human peripheral blood mononuclear
cells. J. Med. Virol. 2008; 80:134-146.
8. Elita W, Adityo S, Leonard N. Demam Berdarah Dengue. Dalam: Chris T, et
al, editor. Kapita Selekta Kedokteran. 2nd ed. Jakarta: Media Aesculapius;
2014.
9. Suhendro, Leonard N, Khie C, Herdiman TP. Demam Berdarah Dengue.
Dalam: Aru WS, et al, editor. Ilmu Penyakit Dalam. 5th ed. Jakarta: Interna
Publishing; 2009.

27
 28

10. World Health Organization. Comprehensive Guidelines for Prevention and

Control of Dengue and Dengue Haemorrhagic Fever; 2011.